These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8354709)

  • 1. Models of cognitive deficit and statistical hypotheses: multiple sclerosis, an example.
    Ryan L; Clark CM; Klonoff H; Paty D
    J Clin Exp Neuropsychol; 1993 Jul; 15(4):563-77. PubMed ID: 8354709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis.
    Kalmar JH; Gaudino EA; Moore NB; Halper J; Deluca J
    Neuropsychology; 2008 Jul; 22(4):442-9. PubMed ID: 18590356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response variability is associated with self-reported cognitive fatigue in multiple sclerosis.
    Bruce JM; Bruce AS; Arnett PA
    Neuropsychology; 2010 Jan; 24(1):77-83. PubMed ID: 20063948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness of deficit in multiple sclerosis.
    Sherman TE; Rapport LJ; Ryan KA
    J Clin Exp Neuropsychol; 2008 Apr; 30(3):301-11. PubMed ID: 17852617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis.
    Christodoulou C; Melville P; Scherl WF; Morgan T; MacAllister WS; Canfora DM; Berry SA; Krupp LB
    J Int Neuropsychol Soc; 2005 Sep; 11(5):614-9. PubMed ID: 16212689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between coping, cognitive dysfunction and depression in multiple sclerosis.
    Arnett PA; Higginson CI; Voss WD; Randolph JJ; Grandey AA
    Clin Neuropsychol; 2002 Aug; 16(3):341-55. PubMed ID: 12607147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis.
    Bagnato F; Salman Z; Kane R; Auh S; Cantor FK; Ehrmantraut M; Gallo A; Ikonomidou VN; Ohayon J; Pellicano C; Stern SK; McFarland HF
    Mult Scler; 2010 Oct; 16(10):1203-12. PubMed ID: 20699284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Ghaffar O; Feinstein A
    Neurology; 2008 Jul; 71(3):164-9. PubMed ID: 18272863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cognitive burden of multiple sclerosis in children.
    Banwell BL; Anderson PE
    Neurology; 2005 Mar; 64(5):891-4. PubMed ID: 15753431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The possibilities of neuropsychological rehabilitation in multiple sclerosis].
    Rosti-Otajärvi E; Hämäläinen P
    Duodecim; 2010; 126(24):2845-52. PubMed ID: 21268907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns.
    Tiemann L; Penner IK; Haupts M; Schlegel U; Calabrese P
    Mult Scler; 2009 Oct; 15(10):1164-74. PubMed ID: 19667010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive functioning in children and adolescents with multiple sclerosis.
    MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB
    Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropsychological impairments in non-demented patients with multiple sclerosis].
    Smilković P; Ocić G; Filipović S; Lević Z; Drulović J
    Srp Arh Celok Lek; 1994; 122(1-2):19-21. PubMed ID: 17972795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in cognitive impairment in multiple sclerosis.
    Beatty WW; Aupperle RL
    Clin Neuropsychol; 2002 Dec; 16(4):472-80. PubMed ID: 12822056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular size, cognitive function and depression in patients with multiple sclerosis.
    Clark CM; James G; Li D; Oger J; Paty D; Klonoff H
    Can J Neurol Sci; 1992 Aug; 19(3):352-6. PubMed ID: 1393845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of an Internet version of the Multiple Sclerosis Neuropsychological Questionnaire.
    Akbar N; Honarmand K; Kou N; Levine B; Rector N; Feinstein A
    Mult Scler; 2010 Dec; 16(12):1500-6. PubMed ID: 20813773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Audio Recorded Cognitive Screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics.
    Lechner-Scott J; Kerr T; Spencer B; Agland S; Lydon A; Schofield PW
    Mult Scler; 2010 Sep; 16(9):1126-33. PubMed ID: 20621944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between global cognitive decline and depressive symptoms in multiple sclerosis.
    Barwick FH; Arnett PA
    Clin Neuropsychol; 2011 Feb; 25(2):193-209. PubMed ID: 21246447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.